Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
930studies shown
Showing 541-552 of 930
Drug study icon
CompletedNCT00044616

Relapse Prevention for Bipolar Type-II Disorder

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 100 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Bipolarity, Depression
Other study type icon
CompletedNCT05956483

Accuracy of Rapid Mood Screener for depression

This study is completed in the United States. It is testing accuracy of Rapid Mood Screener for depression.

Remote / online
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOtherOver 18 Years
Countries
United States
Sponsor
AbbVie
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02466685

Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Herbert Meltzer
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00183443

Treatment of Mania Symptoms With Drug Therapy

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Palo Alto Veterans Institute for Research
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT00813800

Varenicline in Bipolar Depressed Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mark Frye
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00641927

Antidepressant Therapy for Bipolar II Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugOver 18 Years
Countries
United States
Sponsor
Stanley Medical Research Institute
Condition
Bipolarity, Depression
Drug study icon
WithdrawnNCT05060549

Dopamine D3 Receptor Occupancy in Depression in bipolarity

This study is looking at whether a digital support tool can help people with Depression in bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Bipolarity, Depression
Behavioral study icon
WithdrawnNCT06384521

Lifestyle MIND- Feasibility of Wait-list Control

This study exists to compare options and see whether questionnaires and follow-up reports offers something meaningfully different. Researchers are trying to understand whether questionnaires and follow-up reports can better prevent setbacks and support longer-term stability.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, Bipolarity, ...BehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Condition
Schizophrenia, Bipolarity, ...
Other study type icon
CompletedNCT07043803

Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders

This study is looking at whether a digital support tool can help people with Schizophenia Disorder, schizoaffective disorder, or bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityOtherOver 18 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00223496

12- Week Open Label Treatment of Refractory Depression in bipolarity

This study exists to better understand the safety of this type of care and how manageable it feels in practice. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Condition
Bipolarity, Depression
Drug study icon
TerminatedNCT02389712

16-week Comparative Effectiveness study of Lamotrigine vs. Fluoxetine for Depression in bipolarity

This study exists to explore whether the medication Lamotrigine could improve care and understanding. Researchers are trying to understand how people respond to the medication Lamotrigine in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.